|
1）Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996; 12: 24-30
|
|
|
|
2）Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992; 120: 38-43
|
|
|
|
|
|
3）Lin SH, Cheng NL, Hsu YJ, et al. Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis. 2004; 43: 304-12
|
|
|
|
|
|
4）Lin SH, Shiang JC, Huang CC, et al. Phenotype and genotype analysis in Chinese patients with Gitelman’s syndrome. J Clin Endocrinol Metab. 2005; 90: 2500-7
|
|
|
|
|
|
5）Favre GA, Nau V, Kolb I, et al. Localization of tubular adaptation to renal sodium loss in Gitelman syndrome. Clin J Am Soc Nephrol. 2012; 7: 472-8
|
|
|
|
|
|
6）Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2＋reabsorption and reduced Mg2＋ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005; 115: 1651-8
|
|
|
|
|
|
7）Reilly RF, Huang CL. The mechanism of hypocalciuria with NaCl cotransporter inhibition. Nat Rev Nephrol. 2011; 7: 669-74
|
|
|
|
|
|
8）Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med. 2009; 360: 1960-70
|
|
|
|
|
|
9）Scholl UI, Choi M, Liu T, et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A. 2009; 106: 5842-7
|
|
|
|
|
|
10）Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011; 26: 1789-802
|
|
|
|
|
|
11）Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet. 1997; 17: 171-8
|
|
|
|
|
|
12）Bianchetti MG, Edefonti A, Bettinelli A. The biochemical diagnosis of Gitelman disease and the definition of “hypocalciuria”. Pediatr Nephrol. 2003; 18: 409-11
|
|
|
|
|
|
13）Nozu K, Fu XJ, Nakanishi K, et al. Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR. Pediatr Res. 2007; 62: 364-9
|
|
|
|
|
|
14）Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. J Clin Endocrinol Metab. 2010; 95: E511-8
|
|
|
|
|
|
15）Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002; 112: 183-90
|
|
|
|
|
|
16）Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007; 2: 454-60
|
|
|
|
|
|
17）Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002; 417: 447-52
|
|
|
|
|
|
18）Anzai N, Ichida K, Jutabha P, et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem. 2008; 283: 26834-8
|
|
|
|
|
|
19）Matsuo H, Chiba T, Nagamori S, et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet. 2008; 83: 744-51
|
|
|
|
|
|
20）Shima Y, Nozu K, Nozu Y, et al. Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation. Pediatrics. 2011; 127: e1621-5
|
|
|
|
|
|
21）Dinour D, Gray NK, Campbell S, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol. 2010; 21: 64-72
|
|
|
|
|
|
22）Dinour D, Gray NK, Ganon L, et al. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrol Dial Transplant. 2012; 27: 1035-41
|
|
|
|
|
|
23）Kawamura Y, Matsuo H, Chiba T, et al. Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2). Nucleosides Nucleotides Nucleic Acids. 2011; 30: 1105-11
|
|
|
|
|
|
24）Stiburkova B, Ichida K, Sebesta I. Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia. Mol Genet Metab. 2011; 102: 430-5
|
|
|
|
|
|
25）Stiburkova B, Taylor J, Marinaki AM, et al. Acute kidney injury in two children caused by renal hypouricaemia type 2. Pediatr Nephrol. 2012; 27: 1411-5
|
|
|
|
|
|
26）Hoopes RR Jr, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet. 2005; 76: 260-7
|
|
|
|
|
|
27）Sekine T, Nozu K, Iyengar R, et al. OCRL1 mutations in patients with Dent disease phenotype in Japan. Pediatr Nephrol. 2007; 22: 975-80
|
|
|
|
|
|
28）Shrimpton AE, Hoopes RR Jr, Knohl SJ, et al. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol. 2009; 112: 27-36
|
|
|
|
|
|
29）Hichri H, Rendu J, Monnier N, et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2011; 32: 379-88
|
|
|
|
|
|
30）Bokenkamp A, Bockenhauer D, Cheong HI, et al. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr. 2009; 155: 94-9
|
|
|
|
|
|
31）Thebault S, Alexander RT, Tiel Groenestege WM, et al. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol. 2009; 20: 78-85
|
|
|
|
|
|
32）Hou J, Renigunta A, Gomes AS, et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A. 2009; 106: 15350-5
|
|
|
|
|
|
33）Godron A, Harambat J, Boccio V, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol. 2012; 7: 801-9
|
|
|
|
|
|
34）Adalat S, Woolf AS, Johnstone KA, et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol. 2009; 20: 1123-31
|
|
|
|
|
|
35）Glaudemans B, van der Wijst J, Scola RH, et al. A missense mutation in the Kv1. 1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest. 2009; 119: 936-42
|
|
|
|
|
|
36）Stuiver M, Lainez S, Will C, et al. CNNM2, encoding a basolateral protein required for renal Mg2＋ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet. 2011; 88: 333-43
|
|
|
|
|